Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $92.8700 (0.9%) ($91.0500 - $92.8700) on Fri. Dec. 11, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.53% (three month average) | RSI | 76 | Latest Price | $92.8700(0.9%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 1.5% a day on average for past five trading days. | Weekly Trend | LGND advances 2.6% a week on average for past two weeks. | Market Behavior | Normal for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(56%) IWO(54%) XBI(51%) IWM(50%) IWC(49%) | Factors Impacting LGND price | LGND will decline at least -1.265% in a week (0% probabilities). VIXM(-23%) UUP(-17%) VXX(-15%) UNG(-3%) IGOV(-2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.265% (StdDev 2.53%) | Hourly BBV | 0.8 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $89.87(3.34%) | 10 Day Moving Average | $87.45(6.2%) | 20 Day Moving Average | $85.85(8.18%) | To recent high | -10.9% | To recent low | 15.6% | Market Cap | $1.493b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |